Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICU | Common Stock, par value $0.0001 per share | Award | $0 | +28.1K | +33.07% | $0.00 | 113K | Aug 31, 2023 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ICU | Stock Option (Right to Buy) | 66.5K | Aug 31, 2023 | Common Stock | 66.5K | $1.84 | Direct | F4 |
Id | Content |
---|---|
F1 | The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. Due to an administrative error, the Form 4 filed for the Reporting Person on September 12, 2023 inadvertently overstated the number of shares of Common Stock issued to the Reporting Person on August 31, 2023 by 7,053 shares. This error has been corrected on this Form 4. |
F2 | Due to a rounding error, the Form 4 filed for the Reporting Person on August 17, 2023 inadvertently understated the number of shares of Common Stock issued to the Reporting Person on August 15, 2023 by 1 share. This error has been corrected on this Form 4. |
F3 | Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant. |
F4 | All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant. |